Qianwen Shang, Lian Xue, Aidong Lu, Yueping Jia, YingXi Zuo, Huimin Zeng, Leping Zhang
{"title":"儿童复发/难治性 B 细胞急性淋巴细胞白血病患者接受抗 CD19 CAR T 细胞疗法后无需桥接移植的疗效和安全性","authors":"Qianwen Shang, Lian Xue, Aidong Lu, Yueping Jia, YingXi Zuo, Huimin Zeng, Leping Zhang","doi":"10.1016/j.clml.2024.02.002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":503375,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"37 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and safety of children with relapsed/refractory B-cell acute lymphoblastic leukemia after anti-CD19 CAR T-cell therapy without bridging transplantation\",\"authors\":\"Qianwen Shang, Lian Xue, Aidong Lu, Yueping Jia, YingXi Zuo, Huimin Zeng, Leping Zhang\",\"doi\":\"10.1016/j.clml.2024.02.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":503375,\"journal\":{\"name\":\"Clinical Lymphoma Myeloma and Leukemia\",\"volume\":\"37 8\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma Myeloma and Leukemia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.clml.2024.02.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.clml.2024.02.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Efficacy and safety of children with relapsed/refractory B-cell acute lymphoblastic leukemia after anti-CD19 CAR T-cell therapy without bridging transplantation